Protracted Administration of L-Asparaginase in Maintenance Phase Is the Risk Factor for Hyperglycemia in Older Patients with Pediatric Acute Lymphoblastic Leukemia.

PubWeight™: 0.75^‹?›

🔗 View Article (PMC 4552641)

Published in PLoS One on August 28, 2015

Authors

Hideki Yoshida¹, Toshihiko Imamura¹, Akiko M Saito², Yoshihiro Takahashi³, So-ichi Suenobu⁴, Daiichiro Hasegawa⁵, Takao Deguchi⁶, Yoshiko Hashii⁷, Hirohide Kawasaki⁸, Mikiya Endo⁹, Hiroki Hori⁶, Nobuhiro Suzuki¹⁰, Yoshiyuki Kosaka⁵, Koji Kato¹¹, Keiko Yumura-Yagi¹², Junichi Hara¹³, Megumi Oda¹⁴, Atsushi Sato¹⁵, Keizo Horibe², Japan Association of Childhood Leukemia Study

Author Affiliations

1: Department of Pediatrics, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
2: Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
3: Department of Pediatrics, Aomori Prefectural Central Hospital, Aomori, Japan.
4: Division of General Pediatrics and Emergency Medicine, Department of Pediatrics, Oita University, Oita, Japan.
5: Department of Hematology/Oncology, Hyogo Prefectural Children's Hospital, Kobe, Japan.
6: Department of Pediatrics, Mie University, Tsu, Japan.
7: Department of Pediatrics, Osaka University, Suita, Japan.
8: Department of Pediatrics, Kansai Medical University, Hirakata, Japan.
9: Department of Pediatrics, Iwate Medical University, Morioka, Japan.
10: Department of Pediatrics, Hokkaido Medical Center for Child Health and Rehabilitation, Sapporo, Japan.
11: Department of Hematology Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
12: Yumura Clinic, Osaka, Japan.
13: Department of Pediatric Hematology/Oncology, Osaka City General Hospital, Osaka, Japan.
14: Department of Pediatrics, Okayama University, Okayama, Japan.
15: Department of Pediatric Hematology/Oncology, Miyagi Children's Hospital, Sendai, Japan.

Articles cited by this ↗

Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med (2009) 7.95

Longitudinal study on pubertal insulin resistance. Diabetes (2001) 3.21

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood (2012) 2.82

Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood (2006) 2.45

Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia. J Clin Oncol (2008) 2.29

Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol (2003) 2.15

ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child (2004) 2.01

Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia. Pediatr Blood Cancer (2010) 1.91

L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia. JAMA (1967) 1.78

Insulin resistance in children: consensus, perspective, and future directions. J Clin Endocrinol Metab (2010) 1.73

Hyperglycemia during induction therapy is associated with poorer survival in children with acute lymphocytic leukemia. J Pediatr (2009) 1.71

Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue. Circ Res (2005) 1.68

Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group. J Clin Oncol (2009) 1.58

Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols. J Clin Oncol (2007) 1.37

Toxicity of L-asparginase in children with advanced leukemia. Cancer (1972) 1.36

Malignant hematologic diseases in adolescents and young adults. Blood (2011) 1.32

Molecular mechanism of insulin resistance and obesity. Exp Biol Med (Maywood) (2003) 1.19

Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after induction. Leukemia (2008) 1.13

Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis. Pediatr Blood Cancer (2009) 1.12

Workshop on childhood obesity: summary of the discussion. Am J Clin Nutr (1999) 1.12

Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisone. J Pediatr (1981) 1.10

Diabetic ketoacidosis during therapy for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer (2008) 1.06

Adolescents with acute lymphoblastic leukaemia: emerging from the shadow of paediatric and adult treatment protocols. Pediatr Blood Cancer (2006) 1.03

Prevalence of transient hyperglycemia during induction chemotherapy for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer (2009) 1.02

Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia study (JACLS) ALL F-protocol. Pediatr Blood Cancer (2010) 0.90

Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia. Eur J Cancer (2014) 0.87

Treatment of acute leukemia with L-asparaginase. Recent Results Cancer Res (1970) 0.79

Relative hyperglucagonemia in L-asparaginase-and prednisone-induced glucose intolerance in management of acute lymphocytic leukemia. Clin Pediatr (Phila) (1983) 0.78

Hyperglucagonemia in L-asparaginase induced diabetes mellitus. Am J Pediatr Hematol Oncol (1986) 0.77

Articles by these authors ⇆

An overall characterization of pediatric acute lymphoblastic leukemia with CRLF2 overexpression. Genes Chromosomes Cancer (2014) 0.84

Leukostasis in Children and Adolescents with Chronic Myeloid Leukemia: Japanese Pediatric Leukemia/Lymphoma Study Group. Pediatr Blood Cancer (2015) 0.83

Imatinib use immediately before stem cell transplantation in children with Philadelphia chromosome-positive acute lymphoblastic leukemia: Results from Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Study Ph(+) ALL04. Cancer Med (2015) 0.80

Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study. Int J Hematol (2016) 0.79

Preserved High Probability of Overall Survival with Significant Reduction of Chemotherapy for Myeloid Leukemia in Down Syndrome: A Nationwide Prospective Study in Japan. Pediatr Blood Cancer (2015) 0.77

Outcome after relapse in childhood acute lymphoblastic leukemia. Int J Hematol (2002) 0.77

Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia. Nat Genet (2017) 0.77

BCL2 Inhibitor (ABT-737): A Restorer of Prednisolone Sensitivity in Early T-Cell Precursor-Acute Lymphoblastic Leukemia with High MEF2C Expression? PLoS One (2015) 0.76

Statistical analysis of relation between plasma methotrexate concentration and toxicity in high-dose methotrexate therapy of childhood nonHodgkin lymphoma. Pediatr Blood Cancer (2014) 0.75

Pharmacokinetics and Safety of Defibrotide in Healthy Japanese Subjects. Clin Pharmacol Drug Dev (2016) 0.75

Sorafenib treatment in children with relapsed and refractory neuroblastoma: an experience of four cases. Cancer Med (2016) 0.75

Prognostic value of genetic mutations in adolescent and young adults with acute myeloid leukemia. Int J Hematol (2017) 0.75

Hematopoietic Stem Cell Transplantation for XIAP Deficiency in Japan. J Clin Immunol (2016) 0.75

Double-conditioning regimen consisting of high-dose thiotepa and melphalan with autologous stem cell rescue for high-risk pediatric solid tumors: A second report. Pediatr Blood Cancer (2019) 0.75

The incidence of symptomatic osteonecrosis is similar between Japanese children and children in Western countries with acute lymphoblastic leukaemia treated with a Berlin-Frankfurt-Münster (BFM)95-based protocol. Br J Haematol (2021) 0.75

Acute and late toxicities of pirarubicin in the treatment of childhood acute lymphoblastic leukemia: results from a clinical trial by the Japan Association of Childhood Leukemia Study. Int J Clin Oncol (2016) 0.75

Allogeneic Hematopoietic Stem Cell Transplantation for Adolescents and Young Adults with Acute Myeloid Leukemia. Biol Blood Marrow Transplant (2017) 0.75

Clinical significance of SH2B3 (LNK) expression in paediatric B-cell precursor acute lymphoblastic leukaemia. Br J Haematol (2017) 0.75

Prognostic Impact of Specific Molecular Profiles in Pediatric Acute Megakaryoblastic Leukemia in Non-Down Syndrome. Genes Chromosomes Cancer (2017) 0.75

Title: Prognostic factors of children and adolescents with T-cell acute lymphoblastic leukemia after allogeneic transplantation. Hematol Oncol (2022) 0.75

Transposon-Mediated CD19 Chimeric Antigen Receptor-T Cells Derived From CD45RA-Positive Peripheral Blood Mononuclear Cells Possess Potent and Sustained Antileukemic Function. Front Immunol (2022) 0.75

Allogeneic hematopoietic stem cell transplantation for Chediak-Higashi syndrome. Pediatr Transplant (2015) 0.75